Quarterly report · Q3
2689.TEDINET S100QQLZ
Period2022-07-01 → 2023-03-31
Filed2023-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥82.9bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥81.8bn | 2021-07-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥1.6bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥1.7bn | 2021-07-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.7bn | 2021-07-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥1.6bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.7bn | 2021-07-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.0bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.1bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.0bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥1.1bn | 2021-07-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥41.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥40.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥42.4bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥32.1bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥30.9bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥9.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥8.9bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥171.79 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥80.66 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.29 | 2021-07-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥98.71 | 2022-01-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 23.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥1.2bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥1.2bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | −¥94m |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥1.9bn |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥554,000 |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥142m |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥78.3bn |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥77.2bn |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥1.1bn |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥3.9bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥3.8bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥95m |
| jpcrp040300-q3r_E02928-000SPDreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥148m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-03-31 | ¥84.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-03-31 | ¥82.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥1.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-03-31 | ¥1.7bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-03-31 | −¥1.0bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-03-31 | −¥1.0bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-03-31 | −¥103m |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥1.8bn |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥1.8bn |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥537,000 |
| jpcrp040300-q3r_E02928-000Care Nursing Goodsreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥132m |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥77.5bn |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥76.6bn |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥909m |
| jpcrp040300-q3r_E02928-000Medical Equipmentreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥1.5bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue | 2021-07-01 → 2022-03-31 | ¥3.5bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue external | 2021-07-01 → 2022-03-31 | ¥3.4bn |
| jpcrp040300-q3r_E02928-000SPDreportable segment | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥94m |
| jpcrp040300-q3r_E02928-000SPDreportable segment | segment profit | 2021-07-01 → 2022-03-31 | ¥118m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-03-31 | ¥82.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-03-31 | ¥81.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-03-31 | ¥1.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-03-31 | ¥1.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 356
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |